Effect of Weight Loss From ESG Plus Lifestyle Changes vs. Lifestyle Changes Alone in Sleep Apnea Patients
NCT07082608 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74
Last updated 2025-12-19
Summary
Study Overview:
Obesity and Obstructive Sleep Apnea (OSA) are strongly linked. This study aims to understand whether a procedure called Endoscopic Sleeve Gastroplasty (ESG), along with lifestyle changes like healthy eating and regular exercise, can help improve symptoms of OSA in people with obesity.
What is Obstructive Sleep Apnea (OSA)?
OSA is a condition where your breathing repeatedly stops and starts during sleep. This happens when the airway becomes blocked-often due to extra fat around the neck and throat in people with obesity. These breathing interruptions can lead to poor sleep quality, daytime tiredness, mood issues, and long-term health risks like high blood pressure and heart problems.
Why Does Weight Matter?
Obesity is a major cause of OSA. Being overweight can cause:
Narrowing of the airway
More inflammation in the body
Hormonal changes
Difficulty breathing properly during sleep
Losing weight can reduce these problems, ease OSA symptoms, and help improve sleep. Even a moderate amount of weight loss can make a big difference.
How Can People Lose Weight?
Many people try to lose weight through:
Diet changes
Exercise
Behavioural changes like mindful eating
These methods can help, but some people find it hard to lose enough weight or keep it off. That's where medical procedures like ESG can help.
What is ESG (Endoscopic Sleeve Gastroplasty)?
ESG is a non-surgical, minimally invasive weight-loss procedure. It works by reducing the size of your stomach using stitches (done through a tube inserted through your mouth-no cuts or incisions on the body). A smaller stomach means you feel full sooner and eat less.
Benefits of ESG:
Helps you lose weight (up to 20% of total body weight)
Lower risk of complications than traditional surgery
Short recovery time
No hospital stay in most cases
What Does the Research Say So Far?
Some early studies have shown that ESG can help people lose a significant amount of weight and may also improve conditions related to obesity, such as OSA.
One study followed 99 people for a year after ESG. About 30% had OSA at the start. After the procedure, many reported improvement in their OSA symptoms.
Another study compared ESG with a more invasive surgery (laparoscopic sleeve gastrectomy or LSG). While LSG led to more weight loss, both groups showed similar improvements in OSA symptoms.
This shows that ESG may be a good option for improving OSA, but more research is needed to fully understand its benefits.
Why Is This Study Important?
With obesity and OSA becoming more common, it is important to find effective and safe treatments. This study will help us learn:
How much ESG can improve sleep and breathing in people with OSA
Whether combining ESG with lifestyle changes is better than lifestyle changes alone
How ESG impacts other health problems linked to obesity
What We Hope to Learn:
We believe that weight loss from ESG will:
Reduce the severity of OSA
Improve sleep quality
Improve overall health
The results of this study could help guide future treatment options for people with obesity and sleep apnea.
Conditions
- OSA - Obstructive Sleep Apnea
Interventions
- DEVICE
-
Endoscopic Sleeve Gastropathy
Weight loss through diet, exercise, and behavioural changes positively impacts sleep quality. Reduction in body weight can alleviate OSA symptoms and improve overall sleep architecture1,2,3 Surgical weight loss procedures play a crucial role in managing obesity-related health issues, including OSA.4 Endobariatric procedures, including Endoscopic Sleeve Gastroplasty (ESG), have gained attention as a weight loss solution with the potential for improving obesity-related health issues. ESG involves suturing the stomach to reduce its size, limiting food intake. Unlike traditional bariatric surgeries, ESG doesn't require incisions. ESG has shown promise in achieving clinically significant weight loss, up to 20% of TBWL. By reducing stomach capacity, it promotes satiety and calorie restriction. ESG is generally safe, with fewer complications compared to more invasive procedures
- OTHER
-
Lifestyle Modification alone
Participants will follow a structured program involving a low-calorie diet (typically 1200-1500 kcal/day), regular physical activity (150 minutes of moderate-intensity exercise per week), and behavioural therapy sessions.
Sponsors & Collaborators
-
Asian Institute of Gastroenterology, India
lead OTHER
Principal Investigators
-
Rakesh Kalapala, MD, DNB · Asian Institute of Gastroeterology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-19
- Primary Completion
- 2029-05-19
- Completion
- 2029-05-19
Countries
- India
Study Locations
More Related Trials
-
Cost-effectiveness Study of a Lifestyle Change Program for the Treatment of OSA and Obesity: Hospital-Primary Care.
NCT04296721 ·Status: COMPLETED ·Phase: NA
-
Impact of Automatic Positive Airway Pressure on Treatment Compliance in OSA Patients Awaiting Bariatric Surgery
NCT02209220 ·Status: COMPLETED ·Phase: NA
-
Lifestyle Modification Program to Treat Obstructive Sleep Apnea Patients
NCT01384760 ·Status: COMPLETED ·Phase: NA
-
Lifestyle Program for Obstructive Sleep Apnea With Severe Obesity
NCT05343000 ·Status: COMPLETED ·Phase: NA
-
Pragmatic Obstructive Sleep Apnea Weight Loss Trial Assessing Effectiveness and Reach
NCT05104450 ·Status: COMPLETED ·Phase: NA
-
OBese Patients With Obstructive Sleep Apnea Syndrome(OSAS) and EXercise Training
NCT01155271 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Stellate Ganglion Block for the Treatment of Obstructive Sleep Apnea
NCT06319612 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Reducing Obstructive Sleep Apnea After Hypoglossal Nerve Stimulation Through Mandibular Advancement
NCT07132307 ·Status: RECRUITING ·Phase: NA
-
Enhanced Respiratory Polygraphy in Suspected OSA
NCT05949853 ·Status: UNKNOWN
-
Mandibular Advancement vs Home Treatment for Primary Snoring
NCT05756647 ·Status: COMPLETED ·Phase: PHASE2
-
Observation of Clinical Effect of New Oropharyngeal Airway in Patients With OSHAS During Painless Gastroenteroscopy
NCT06594380 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of the Comfort of a Continuous Positive Airway Pressure Nasal Mask in the Treatment of OSA Syndrome
NCT04925739 ·Status: COMPLETED
-
Injection Snoreplasty and Oropharyngeal Exercises
NCT02568761 ·Status: UNKNOWN ·Phase: NA
-
The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA)
NCT02730273 ·Status: COMPLETED ·Phase: NA
-
Prescision Medicine in Obstructive Sleep Apnea, Cardiovascular and Cerebrovascular Disease: AI Electrocardiogram Patch Does it All
NCT05566860 ·Status: UNKNOWN ·Phase: NA
-
Lifestyle Modification Using an App in OSA
NCT03189940 ·Status: COMPLETED ·Phase: NA
-
The Effect of Obstructive Sleep Apnea Operations on the Swallowing Function
NCT03082170 ·Status: UNKNOWN ·Phase: NA
-
Servo-Ventilation In-lab PSG Evaluation
NCT02808338 ·Status: COMPLETED ·Phase: NA
-
The Effect of High Intensity Interval Exercise and Myofunctional Therapy on Obstructive Sleep Apnea
NCT05311280 ·Status: UNKNOWN ·Phase: NA
-
Impact of Muscle Training Device on Non-Severe OSA
NCT06910930 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Treatment Efficacy and Comfort of a Modified Positive Airway Pressure Device to Treat Obstructive Sleep Apnea.
NCT02214238 ·Status: COMPLETED ·Phase: NA
-
Time Restricted Eating in Sleep Apnea
NCT06047496 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk
NCT01156116 ·Status: COMPLETED ·Phase: NA
-
Weight Loss and Obstructive Sleep Apnea
NCT02206126 ·Status: COMPLETED ·Phase: NA
-
Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver Disease
NCT02728765 ·Status: COMPLETED ·Phase: NA